NewslettersExtracellular Matrix NewsVerteporfin Ameliorates Fibrotic Aspects of Dupuytren’s Disease Nodular Fibroblasts Irrespective the Activation State of the CellsBy Danielle Corrigan - August 18, 20220284Researchers investigated whether verteporfin was able to inhibit the activation and subsequent differentiation of Dupuytren’s disease nodular fibroblasts into myofibroblasts.[Scientific Reports]Full Article